作者: Allison Ryan , Nathan Hunkapiller , Milena Banjevic , Naresh Vankayalapati , Nicole Fong
DOI: 10.1159/000442931
关键词:
摘要: Objective: To validate an updated version (Version 2) of a single-nucleotide polymorphism (SNP)-based noninvasive prenatal test (NIPT) and to determine the likelihood success when testing for fetal aneuploidies following redraw. Methods: Version 2 was analytically validated using 587 plasma samples with known genotype (184 trisomy 21, 37 18, 15 13, 9 monosomy X, 4 triploidy 338 euploid). Sensitivity, specificity no-call rate were calculated, fetal-fraction adjustment applied enable projection these values in commercial distribution. Likelihood second blood draw computed based on fraction maternal weight from first draw. Results: Validation this methodology yielded high sensitivities (≥99.4%) specificities (100%) all conditions tested observed 2.3%. The threshold sample calling reduced 2.8% fraction. redraw driven by higher initial fractions lower weights, being more significant variable. Conclusions: enhanced SNP-based NIPT method showed comparison earlier version, while maintaining sensitivity specificity.